Summary:
- The article discusses a study published in *JAMA Ophthalmology* identifying a potential association between the use of GLP-1 receptor agonist medications (such as Ozempic and Wegovy) and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can cause sudden vision loss.
- While researchers emphasize that the study demonstrates a correlation rather than a direct causal link, it highlights the importance of ongoing clinical surveillance and patient awareness regarding potential ocular side effects associated with these widely prescribed weight-loss and diabetes treatments.